Stem Cell-Derived Blood Products for Therapeutic Use: Technology Improvement (R41)

Archived

National Institutes of Health

View on Grants.gov 📝 Build a proposal template ★ Save

Description

The primary objective of this funding opportunity announcement is to support the development of improved techniques and tools to enhance the production of clinically-relevant, functional stem cell-derived red blood cells or platelets in a more efficient and cost-effective manner. The research supported will develop and enhance technologies that enable the production of functional stem cell-based therapies with potential commercial and clinical viability.

Who can apply

  • Small businesses

Contact

NIH OER Webmaster<br/>FBOWebmaster@OD.NIH.GOV<br/>
FBOWebmaster@OD.NIH.GOV

Key dates & funding
  • PostedNov 7, 2014
  • ClosesFeb 20, 2015
  • Award ceiling$225,000
  • Program funding$675,000
  • Expected awards3
  • CFDA93.839
Categories
Health

Pro insight

Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.

Unlock with Pro